A bill to require the reporting of certain information and to prescribe conduct related to drugs and the federal 340B program; to prescribe civil sanctions; to allow for the promulgation of rules; and to provide for the powers and duties of certain state officers and entities.
House Bill No. 4878 introduces new transparency, reporting, and compliance requirements for manufacturers, wholesalers, and hospitals participating in Michigan's 340B drug pricing program, with the aim of protecting 340B entities' access to discounted drugs and ensuring program savings benefit patient and community services.
Introduced
by
Referred to the Committee on Health Policy
